BioAmber Closes $45 Million Series B Financing Round

BioAmber Inc. has raised $45 million in a Series B financing. . The round was led by NAXOS Capital Partners, a European based growth capital fund. Mitsui & Co. Venture Partners, a new investor, participated in the round, which was co-led by Sofinnova Partners. Cliffton Group of Montreal, Quebec, also participated. BioAmber is a Minneapolis, Minn.-based renewable chemistry company. It plans to use the financing to accelerate the commercialization of succinic acid and modified PBS, a biodegradable plastic offering better heat resistance and processability than other biopolymers.

4 May 2011•3 mins read
Feature image
LinkedInXEmail
LinkedInXEmail